|
1
|
Rajguru JP, Maya D, Kumar D, Suri P,
Bhardwaj S and Patel ND: Update on psoriasis: A review. J Family
Med Prim Care. 9:20–24. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cruz NFSD, Brandão LS, Cruz SFSD, Cruz
SASD, Pires CAA and Carneiro FRO: Ocular manifestations of
psoriasis. Arq Bras Oftalmol. 81:219–225. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bolognia JL, Schaffer JV and Cerroni L:
Dermatology. 4th edition. Elsevier, London, pp141-149, 2018.
|
|
4
|
Al Akrash LS, Al Semari MA and Al Harithy
R: Ocular manifestations of dermatological diseases part I:
Infectious and inflammatory disorders. Int J Dermatol. 60:5–11.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Demerdjieva Z, Mazhdrakova I and Tsankov
N: Ocular changes in patients with psoriasis. Clin Dermatol.
37:663–667. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rehal B, Modjtahedi BS, Morse LS, Schwab
IR and Maibach HI: Ocular psoriasis. J Am Acad Dermatol.
65:1202–1212. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chimenti MS, Triggianese P, Salandri G,
Conigliaro P, Canofari C, Caso F, Costa L, Nucci C, Aiello F,
Cesareo M and Perricone R: A multimodal eye assessment in psoriatic
arthritis patients sine-psoriasis: Evidence for a potential
association with systemic inflammation. J Clin Med.
9(719)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ghalamkarpour F, Baradaran-Rafii A,
Sadoughi MM, Abdollahimajd F, Younespour S, Zargari O and Rudolph
RI: Ocular findings in patients with psoriasis: Is it related to
the side effects of treatment or to psoriasis itself? A
case-control study. J Dermatolog Treat. 31:27–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lerman S: Ocular side effects of accutane
therapy. Lens Eye Toxic Res. 9:429–438. 1992.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fraunfelder FW: Ocular side effects
associated with isotretinoin. Drugs Today (Barc). 40:23–27.
2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lebowitz MA and Berson DS: Ocular effects
of oral retinoids. J Am Acad Dermatol. 19:209–211. 1988.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kilic B, Dogan U, Parlak AH, Goksugur N,
Polat M, Serin D and Ozmen S: Ocular findings in patients with
psoriasis. Int J Dermatol. 52:554–559. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shainhouse T: Ocular manifestations of
psoriasis. EC Ophthalmol. 5:172–176. 2017.
|
|
14
|
Maitray A, Bhandary AS, Shetty SB and
Kundu G: Ocular manifestations in psoriasis: Original research
article. Int J Ocul Oncol Oculoplasty. 2:123–131. 2016.
|
|
15
|
Jäger K, Garreis F, Posa A, Dunse M and
Paulsen FP: Functional relationship between cationic amino acid
transporters and beta-defensins: Implications for dry skin diseases
and the dry eye. Ann Anat. 192:65–69. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Freeman AK, Linowski GJ, Brady C, Lind L,
Vanveldhuisen P, Singer G and Lebwohl M: Tacrolimus ointment for
the treatment of psoriasis on the face and intertriginous areas. J
Am Acad Dermatol. 48:564–568. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lee DJ: Intraocular implants for the
treatment of autoimmune uveitis. J Funct Biomater. 6:650–666.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Durrani K and Foster CS: Psoriatic
uveitis: A distinct clinical entity? Am J Ophthalmol. 139:106–111.
2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Biggioggero M, Crotti C, Becciolini A,
Miserocchi E and Favalli EG: The management of acute anterior
uveitis complicating spondyloarthritis: Present and future. Biomed
Res Int. 2018(9460187)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dinu A, Bucur S, Olteanu R, Constantin T,
Raducan A, Baetu M and Constantin MM: Psoriatic arthritis: A
permanent new challenge for dermatologists (review). Exp Ther Med.
20:47–51. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vallet H, Seve P, Biard L, Baptiste
Fraison J, Bielefeld P, Perard L, Bienvenu B, Abad S, Rigolet A,
Deroux A, et al: Infliximab versus adalimumab in the treatment of
refractory inflammatory uveitis: A multicenter study from the
french uveitis network. Arthritis Rheumatol. 68:1522–1530.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yang P, Zheng M, Zhang L, Du L, Zhou Q,
Cai T, Qi J, Liang L and Kijlstra A: Uveitis in Chinese patients
with psoriasis. Ocul Immunol Inflamm. 25:855–865. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gladman DD: Clinical aspects of the
spondyloarthropathies. Am J Med Sci. 316:234–238. 1998.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ionescu RA: Uveitis as an extraarticular
manifestation in spondyloarthritis. Rom J Rheumatol. 29:147–150.
2020.
|
|
25
|
Lee CY, Chen HC, Lin HW, Huang JY, Lin TL,
Yang CH, Yeh CB, Lin HY and Yang SF: Increased risk of keratopathy
after psoriasis: A nationwide population-based study. PLoS One.
13(e0201285)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lambert JR and Wright V: Eye inflammation
in psoriatic arthritis. Ann Rheum Dis. 35:354–356. 1976.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Clarke SLN, Sen ES and Ramanan AV:
Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol
Online J. 14(27)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fraga NA, Oliveira Mde F, Follador I,
Rocha Bde O and Rêgo VR: Psoriasis and uveitis: A literature
review. An Bras Dermatol. 87:877–883. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dalvi SR, Yildirim R and Yazici Y:
Behcet's syndrome. Drugs. 72:2223–2241. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pan J, Kapur M and McCallum R:
Noninfectious immune-mediated uveitis and ocular inflammation. Curr
Allerg Asthma Rep. 14(409)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yanoff M and Cameron D: Diseases of the
visual system. In: Goldman's Cecil Medicine. 24th edition. Goldman
L and Schafer AI (eds). Elsevier Saunders, Philadelphia, PA,
pp2426-2442, 2012.
|
|
32
|
Caspi RR: A look at autoimmunity and
inflammation in the eye. J Clin Invest. 120:3073–3083.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Singla MB, Hodge DK and Moawad FJ:
Infliximab-induced anterior uveitis in a patient with ulcerative
colitis. J Crohns Colitis. 9(432)2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee S, Park YJ and Lee JY: The effect of
tumor necrosis factor-alpha inhibitors on uveitis in patients with
ankylosing spondylitis. J Korean Med Sci. 34(e278)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yamaguchi K, Hayashi T, Takahashi G,
Momose M, Asahina A and Nakano T: Successful certolizumab pegol
treatment of chronic anterior uveitis associated with psoriasis
vulgaris. Case Rep Ophthalmol. 9:499–503. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lu J, Tang S, Yu N, Yi X and Li Y:
Successful secukinumab treatment of erythrodermic psoriasis and
psoriatic arthritis concomitant with severe noninfectious uveitis:
A case report. J Int Med Res: Nov 8, 2020 (Epub ahead of print).
doi: 10.1177/0300060520969494.
|
|
37
|
Mugheddu C, Atzori L, Del Piano M, Lappi
A, Pau M, Murgia S, Zucca I and Rongioletti F: Successful
ustekinumab treatment of noninfectious uveitis and concomitant
severe psoriatic arthritis and plaque psoriasis. Dermatol Ther.
30:2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Benucci M, Damiani A, Li Gobbi F, Grossi
V, Infantino M, Manfredi M, Niccoli L and Cantini F: Therapeutic
potential of ixekizumab in the treatment of ankylosing spondylitis:
A review on the emerging clinical data. Ther Clin Risk Manag.
16:287–297. 2020.
|
